 Laura Sherlock
Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 2 | 2023 | 476 | 1.300 |
Why?
| | Acetaminophen | 5 | 2022 | 241 | 1.280 |
Why?
| | Endotoxemia | 3 | 2023 | 86 | 1.050 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2022 | 125 | 0.890 |
Why?
| | Liver | 6 | 2023 | 1637 | 0.810 |
Why?
| | Micronutrients | 1 | 2023 | 78 | 0.800 |
Why?
| | NF-kappa B | 5 | 2024 | 641 | 0.780 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 329 | 0.760 |
Why?
| | Selenoproteins | 1 | 2020 | 8 | 0.730 |
Why?
| | Lung | 6 | 2023 | 3561 | 0.360 |
Why?
| | Lung Injury | 2 | 2021 | 198 | 0.320 |
Why?
| | Mice, Inbred C57BL | 4 | 2024 | 4694 | 0.260 |
Why?
| | Infant, Newborn | 4 | 2023 | 5047 | 0.250 |
Why?
| | Hepatocytes | 2 | 2024 | 195 | 0.220 |
Why?
| | Transcription Factor RelA | 1 | 2024 | 82 | 0.220 |
Why?
| | Vitamin A | 1 | 2023 | 52 | 0.210 |
Why?
| | Vitamin K | 1 | 2023 | 42 | 0.210 |
Why?
| | Vitamins | 1 | 2023 | 151 | 0.190 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2022 | 176 | 0.190 |
Why?
| | I-kappa B Proteins | 1 | 2022 | 79 | 0.190 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2022 | 50 | 0.190 |
Why?
| | Dilatation | 1 | 2022 | 60 | 0.190 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 41 | 0.180 |
Why?
| | Mice | 8 | 2024 | 14871 | 0.180 |
Why?
| | Selenium | 1 | 2020 | 31 | 0.180 |
Why?
| | Infant | 2 | 2023 | 7964 | 0.170 |
Why?
| | Intensive Care, Neonatal | 1 | 2020 | 39 | 0.170 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2021 | 270 | 0.170 |
Why?
| | Mice, Knockout | 2 | 2022 | 2570 | 0.170 |
Why?
| | Animals | 9 | 2024 | 31708 | 0.170 |
Why?
| | Spleen | 1 | 2020 | 487 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2024 | 1140 | 0.160 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 141 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2023 | 641 | 0.150 |
Why?
| | Interleukin-6 | 1 | 2022 | 676 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2023 | 687 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2021 | 468 | 0.130 |
Why?
| | Kidney | 1 | 2020 | 1188 | 0.110 |
Why?
| | Male | 7 | 2023 | 55606 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1395 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 600 | 0.100 |
Why?
| | Lung Diseases | 1 | 2018 | 701 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1729 | 0.100 |
Why?
| | Cytochrome P-450 CYP2E1 | 2 | 2021 | 25 | 0.090 |
Why?
| | Hospitalization | 1 | 2020 | 1752 | 0.090 |
Why?
| | Glycolysis | 2 | 2021 | 227 | 0.090 |
Why?
| | Signal Transduction | 1 | 2022 | 4515 | 0.080 |
Why?
| | Animals, Newborn | 2 | 2022 | 778 | 0.080 |
Why?
| | Female | 5 | 2023 | 59520 | 0.070 |
Why?
| | Humans | 5 | 2023 | 114699 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2024 | 60 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 25 | 0.050 |
Why?
| | Tryptophan Hydroxylase | 1 | 2022 | 52 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2022 | 113 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2022 | 141 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 109 | 0.050 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2022 | 120 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2023 | 362 | 0.050 |
Why?
| | Serotonin | 1 | 2022 | 292 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 155 | 0.040 |
Why?
| | Homeostasis | 1 | 2024 | 573 | 0.040 |
Why?
| | Pregnancy | 2 | 2022 | 5520 | 0.040 |
Why?
| | Sheep | 1 | 2022 | 764 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 299 | 0.040 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2020 | 152 | 0.040 |
Why?
| | Gene Expression | 1 | 2024 | 1421 | 0.040 |
Why?
| | Alveolar Epithelial Cells | 1 | 2018 | 93 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2023 | 720 | 0.040 |
Why?
| | Hypoxia | 1 | 2022 | 958 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2021 | 3535 | 0.020 |
Why?
| | Hydrogels | 1 | 2018 | 573 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2018 | 1701 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4100 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2020 | 12555 | 0.010 |
Why?
|
|
Sherlock's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|